Menopause Leave: The Global Policy Landscape in 2026

MARKABLE Research Team · May 2026 · 7 min read

Until recently, the idea of menopause-specific workplace protections would have been considered unlikely in most countries. That is changing rapidly. In the space of just a few years, menopause has moved from a largely invisible workplace issue to the subject of national legislation, employment tribunal rulings, and corporate policy innovation.

Here is where things stand around the world as of 2026, and what it means for employers navigating a shifting legal landscape.

1 in 10

women have left a job due to menopause symptoms

Source: Fawcett Society, Menopause and the Workplace, 2022

Country-by-country overview

Legislation enacted

United Kingdom

The UK leads the global landscape. The Employment Rights Act 2025, which received Royal Assent in December 2025, requires employers with 250 or more staff to publish menopause action plans by spring 2027. This makes the UK the first country to embed menopause-specific obligations into primary employment legislation.

Prior to the Act, menopause protections were already emerging through case law. The Equality Act 2010 has been interpreted to cover menopause symptoms under sex, age, and disability discrimination provisions. Notable tribunal cases including Merchant v BT (2021) and Rooney v Leicester City Council (2022) established important precedents.

Legislation enacted

Spain

Spain's 2023 menstrual leave legislation (part of broader reproductive health reforms) included provisions that touch on menopause. The law recognizes "incapacitating menstruation" as grounds for paid medical leave and has opened discussion about extending similar protections to menopause symptoms. While menopause-specific leave is not yet codified, Spain's framework represents one of the most progressive approaches to reproductive health in the workplace globally.

In development

Australia

Australia has seen significant momentum. Several parliamentary inquiries have examined menopause workplace impacts, and the Australian Human Rights Commission has published guidance on menopause as a workplace issue. Some Australian states have begun considering menopause-specific workplace protections. In the private sector, major employers including Telstra and the Commonwealth Bank have introduced menopause policies ahead of any legislative mandate.

Existing framework

Japan

Japan's existing workplace health framework includes provisions that can apply to menopause, though not specifically named as such. The country's occupational health legislation requires employers to support employee health broadly, and Japan's aging workforce has made menopause a more visible topic. Some Japanese companies have introduced specific menopause support programmes, including Kao Corporation's widely cited employee wellness initiative. Japan's seirikyuka (menstrual leave) system, which has existed since 1947, provides a cultural and legal precedent for reproductive health leave.

In discussion

European Union

The European Parliament has discussed menopause workplace protections as part of broader gender equality and occupational health directives. While no EU-wide menopause legislation has been enacted, the European Agency for Safety and Health at Work (EU-OSHA) has published guidance on menopause as an occupational health issue. Individual member states, particularly Ireland and the Netherlands, have active policy discussions underway.

Corporate-led

United States

The US has no federal menopause-specific workplace legislation, and none appears imminent. However, corporate adoption is growing. Companies including Bank of America, Bristol-Myers Squibb, and several tech firms have introduced menopause benefits, often as part of broader women's health or reproductive health programmes. The Americans with Disabilities Act (ADA) may provide some protection for severe menopause symptoms, though this has not been widely tested in courts.

Key tribunal cases shaping the landscape

Legal precedents are often as influential as legislation itself. Several tribunal and court cases have shaped how menopause is treated in employment law:

The pattern in tribunal rulings is consistent: Employers who fail to consider menopause as a potential factor in performance, absence, or workplace difficulties are increasingly found to have acted unfairly or discriminated. The direction of travel is clear.

What the best employer policies look like

Beyond legal compliance, a growing number of organizations are implementing menopause support as a strategic workforce initiative. The most effective policies share several features:

Dedicated menopause leave or flexible absence

Some employers offer specific menopause leave days (typically 5-10 per year), while others adjust their existing absence management policies to ensure menopause-related absences are not counted against employees in performance or capability reviews.

Environmental adjustments

Practical changes to the physical work environment: temperature control, access to fans, breathable dress codes, proximity to washroom facilities, and quiet rest areas. These are low-cost and high-impact.

Healthcare access

Access to menopause-specialist healthcare through employee benefits, including GP consultations, specialist referrals, and in some cases, coverage for hormone therapy or other treatments.

Manager training

Training for line managers on recognizing menopause symptoms, having supportive conversations, and implementing adjustments. This is consistently cited as one of the most impactful interventions.

Wellness tracking and data

Progressive employers are exploring tools that help employees track their symptoms and hormonal wellness patterns, creating a data-informed basis for conversations with both managers and healthcare providers.

The business case for proactive menopause support

Menopause affects women during what is often the peak of their careers. In most countries, women over 50 are the fastest-growing workforce demographic. The economic case for support is substantial:

Building a menopause-supportive workplace?

MARKABLE provides employers with tools that help employees track hormonal wellness patterns. A proactive, data-informed approach to workforce wellbeing.

Learn About MARKABLE for Employers →

What employers should do now

Regardless of your jurisdiction, the global trend is unmistakable. Here are steps every employer can take:

  1. Audit your current policies. Do your absence, flexible working, and reasonable adjustment policies address menopause? If not, they likely need updating.
  2. Train your managers. This is consistently the highest-impact, lowest-cost intervention. Managers who understand menopause can prevent most workplace difficulties before they escalate.
  3. Talk to your workforce. Anonymous surveys can reveal the scale of impact and the specific adjustments that would help most.
  4. Watch the legal landscape. If you operate across borders, track developments in each jurisdiction. What is voluntary today may become mandatory tomorrow.
  5. Measure and report. The organizations that will navigate this best are those that treat menopause support as a measurable workforce initiative, not a checkbox.

The bottom line

Menopause workplace rights are moving from voluntary to mandatory across multiple jurisdictions. The UK has set the pace with primary legislation, but Australia, Spain, and the EU are not far behind. For global employers, the question is no longer whether to act, but how quickly.

The organizations that move early will retain experienced talent, reduce turnover costs, and build workplaces where women can thrive through every stage of their careers. The cost of inaction is increasingly measurable, and increasingly avoidable.

This article is for informational purposes only and does not constitute legal advice. Employment law varies by jurisdiction and is subject to change. Employers should consult qualified legal counsel for compliance guidance specific to their organization and operating jurisdictions. MARKABLE is a general wellness product and is not a medical device.